Literature DB >> 23388464

Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.

Lela Lackey1, Emily K Law, William L Brown, Reuben S Harris.   

Abstract

Humans have seven APOBEC3 DNA cytosine deaminases. The activity of these enzymes allows them to restrict a variety of retroviruses and retrotransposons, but may also cause pro-mutagenic genomic uracil lesions. During interphase the APOBEC3 proteins have different subcellular localizations: cell-wide, cytoplasmic or nuclear. This implies that only a subset of APOBEC3s have contact with nuclear DNA. However, during mitosis, the nuclear envelope breaks down and cytoplasmic proteins may enter what was formerly a privileged zone. To address the hypothesis that all APOBEC3 proteins have access to genomic DNA, we analyzed the localization of the APOBEC3 proteins during mitosis. We show that APOBEC3A, APOBEC3C and APOBEC3H are excluded from condensed chromosomes, but become cell-wide during telophase. However, APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis. After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic. Both structural motifs as well as size may be factors in regulating chromatin exclusion. Deaminase activity was not dependent on cell cycle phase. We also analyzed APOBEC3-induced cell cycle perturbations as a measure of each enzyme's capacity to inflict genomic DNA damage. AID, APOBEC3A and APOBEC3B altered the cell cycle profile, and, unexpectedly, APOBEC3D also caused changes. We conclude that several APOBEC3 family members have access to the nuclear compartment and can impede the cell cycle, most likely through DNA deamination and the ensuing DNA damage response. Such genomic damage may contribute to carcinogenesis, as demonstrated by AID in B cell cancers and, recently, APOBEC3B in breast cancers.

Entities:  

Keywords:  APOBEC3; DNA cytosine deamination; cancer; cell cycle; mitosis; subcellular localization; uracil

Mesh:

Substances:

Year:  2013        PMID: 23388464      PMCID: PMC3610724          DOI: 10.4161/cc.23713

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  75 in total

1.  AID is required for germinal center-derived lymphomagenesis.

Authors:  Laura Pasqualucci; Govind Bhagat; Mila Jankovic; Mara Compagno; Paula Smith; Masamichi Muramatsu; Tasuku Honjo; Herbert C Morse; Michel C Nussenzweig; Riccardo Dalla-Favera
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

2.  Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.

Authors:  Ryan P Bennett; Vladimir Presnyak; Joseph E Wedekind; Harold C Smith
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

3.  Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.

Authors:  Kuan-Ming Chen; Elena Harjes; Phillip J Gross; Amr Fahmy; Yongjian Lu; Keisuke Shindo; Reuben S Harris; Hiroshi Matsuo
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

4.  Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair.

Authors:  Carol E Schrader; Jeroen E J Guikema; Erin K Linehan; Erik Selsing; Janet Stavnezer
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

5.  Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.

Authors:  Mariana Marin; Sheetal Golem; Kristine M Rose; Susan L Kozak; David Kabat
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

6.  Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.

Authors:  Anna Maria Niewiadomska; Chunjuan Tian; Lindi Tan; Tao Wang; Phuong Thi Nguyen Sarkis; Xiao-Fang Yu
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

7.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

8.  All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition.

Authors:  Masanobu Kinomoto; Takayuki Kanno; Mari Shimura; Yukihito Ishizaka; Asato Kojima; Takeshi Kurata; Tetsutaro Sata; Kenzo Tokunaga
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

9.  Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.

Authors:  Ritu Goila-Gaur; Mohammad A Khan; Eri Miyagi; Sandra Kao; Klaus Strebel
Journal:  Retrovirology       Date:  2007-08-29       Impact factor: 4.602

10.  Population stratification of a common APOBEC gene deletion polymorphism.

Authors:  Jeffrey M Kidd; Tera L Newman; Eray Tuzun; Rajinder Kaul; Evan E Eichler
Journal:  PLoS Genet       Date:  2007-04-20       Impact factor: 5.917

View more
  68 in total

1.  The deaminase APOBEC3B triggers the death of cells lacking uracil DNA glycosylase.

Authors:  Artur A Serebrenik; Gabriel J Starrett; Sterre Leenen; Matthew C Jarvis; Nadine M Shaban; Daniel J Salamango; Hilde Nilsen; William L Brown; Reuben S Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

2.  Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.

Authors:  Joseph C F Ng; Jelmar Quist; Anita Grigoriadis; Michael H Malim; Franca Fraternali
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

3.  In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.

Authors:  Yuki Nakaya; Spyridon Stavrou; Kristin Blouch; Peter Tattersall; Susan R Ross
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

4.  APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.

Authors:  Daniel J Salamango; Jordan T Becker; Jennifer L McCann; Adam Z Cheng; Özlem Demir; Rommie E Amaro; William L Brown; Nadine M Shaban; Reuben S Harris
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

Review 5.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

Review 6.  The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.

Authors:  Abby M Green; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2019-09-13

7.  A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.

Authors:  Adam Z Cheng; Sofia N Moraes; Claire Attarian; Jaime Yockteng-Melgar; Matthew C Jarvis; Matteo Biolatti; Ganna Galitska; Valentina Dell'Oste; Lori Frappier; Craig J Bierle; Stephen A Rice; Reuben S Harris
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

8.  Determinants of Oligonucleotide Selectivity of APOBEC3B.

Authors:  Jeffrey R Wagner; Özlem Demir; Michael A Carpenter; Hideki Aihara; Daniel A Harki; Reuben S Harris; Rommie E Amaro
Journal:  J Chem Inf Model       Date:  2018-09-10       Impact factor: 4.956

9.  Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.

Authors:  In-Ja L Byeon; Chang-Hyeock Byeon; Tiyun Wu; Mithun Mitra; Dustin Singer; Judith G Levin; Angela M Gronenborn
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

10.  RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids.

Authors:  Yuqing Feng; Lai Wong; Michael Morse; Ioulia Rouzina; Mark C Williams; Linda Chelico
Journal:  J Mol Biol       Date:  2018-11-09       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.